The Need For Standardizing Pre-Analytical Sample Handling And Integrating Analytical Workflows For Ensuring Liquid Biopsies Are Ready For Prime-Time: [Essay Example], 603 words GradesFixer
exit-popup-close

Haven't found the right essay?

Get an expert to write your essay!

exit-popup-print

Professional writers and researchers

exit-popup-quotes

Sources and citation are provided

exit-popup-clock

3 hour delivery

exit-popup-persone
close
This essay has been submitted by a student. This is not an example of the work written by professional essay writers.

The Need for Standardizing Pre-analytical Sample Handling and Integrating Analytical Workflows for Ensuring Liquid Biopsies Are Ready for Prime-time

Download Print

Pssst… we can write an original essay just for you.

Any subject. Any type of essay.

We’ll even meet a 3-hour deadline.

Get your price

121 writers online

blank-ico
Download PDF

The dawn of cancer genomics has heralded an unprecedented era of precision medicine, allowing the identification of genome-wide somatic driver alterations that can be used for early cancer diagnosis, prognosis, stratification to optimum therapies and monitoring of developing resistance, as well as predicting which patients are likely to relapse. Currently, clinicians and translational researchers are utilising our vastly improved understanding of the heterogeneous molecular landscape of cancer to stratify patients appropriately to carefully selected targeted treatments with the aim of ensuring patients receive the right treatment at the right time.

Ultimately, there is hope that this will allow clinicians to either cure their patients disease (at the earliest stages) or manage their disease for the longest time possible, while still ensuring the highest possible quality of life (in advanced stages). The current “gold standard” for diagnosing cancer and determining optimal therapeutic strategies is through surgical biopsy. However, this method has several limitations, not least of all its invasiveness. Surgical biopsies are also extremely limited in that they only offer a “snapshot” in space and time of the tumour depending on the disease stage and local area. Further, they are known to be unrepresentative of tumour heterogeneity, potentially resulting in predominance of resistant clones that are refractory to therapy and eventually disease progression/therapy resistance.

Therefore, surgical biopsy cannot offer any indication of treatment efficacy and tumour evolution (especially in the metastatic setting) during a patient’s therapy. Compounding this, most biopsies are archived as formalin-fixed, paraffin embedded blocks that are used for routine pathology, necessitating highly-sensitive methods (such as next-generation sequencing (NGS) and digital polymerase chain reaction (dPCR)) for analysis of very limited amounts of poor quality nucleic acid. However, many of these limitations can be circumvented using liquid biopsies. The liquid biopsy holds huge potential as a more cost-effective, easier, less-invasive method for diagnosing and monitoring cancer, as well as predicting response to many currently available therapies. The liquid biopsy is used as an “umbrella” term that encompasses different analytes that can be identified in blood samples including: circulating tumour cells (CTCs), circulating free DNA (cfDNA), circulating tumour DNA (ctDNA – the tumour-derived fraction of cfDNA), circulating RNA (including circulating microRNA), extracellular vesicles such as exosomes and more recently, platelets (in particular tumour-educated platelets or TEPs) (REF).

Of these, CTCs and ctDNA are currently the most validated analytes and the most likely to translate into routine clinical use within the next 2-5 years due to their proven ability for early cancer diagnosis (REF), to dynamically monitor patient response to therapy (REF), to predict relapse (REF) and offer actionable somatic alterations for stratifying patients to the optimum therapies in real time (REFS). Overall, the liquid biopsy can complement a personalised medicine approach to cancer treatment as well as providing innovative methods towards patient selection in clinical trials. However, despite the huge potential of the liquid biopsy for managing patient therapy, several technical and logistical challenges need to be overcome before it can be truly integrated into routine clinical use.

Of note, there is still no widely accepted consensus regarding pre-analytical blood sample handling, technologies used for extracting cfDNA and CTCs, as well as no routinely used robust and reproducible workflow towards consistent molecular analysis of liquid biopsy analytes – both of which are urgently needed before liquid biopsies can become routinely used in the clinic. Here, we discuss the current status of liquid biopsy testing in patients with solid tumours and the variation in blood sample handling and molecular workflows used to analyse them, focusing on ctDNA and CTCs. Circulating tumour DNAThere are many pre-analytical variables that are inherent in affecting the downstream data obtained from ctDNA analysis.

Remember: This is just a sample from a fellow student.

Your time is important. Let us write you an essay from scratch

100% plagiarism free

Sources and citations are provided

Find Free Essays

We provide you with original essay samples, perfect formatting and styling

Cite this Essay

To export a reference to this article please select a referencing style below:

The Need For Standardizing Pre-Analytical Sample Handling And Integrating Analytical Workflows For Ensuring Liquid Biopsies Are Ready For Prime-Time. (2020, April 12). GradesFixer. Retrieved January 21, 2021, from https://gradesfixer.com/free-essay-examples/the-need-for-standardizing-pre-analytical-sample-handling-and-integrating-analytical-workflows-for-ensuring-liquid-biopsies-are-ready-for-prime-time/
“The Need For Standardizing Pre-Analytical Sample Handling And Integrating Analytical Workflows For Ensuring Liquid Biopsies Are Ready For Prime-Time.” GradesFixer, 12 Apr. 2020, gradesfixer.com/free-essay-examples/the-need-for-standardizing-pre-analytical-sample-handling-and-integrating-analytical-workflows-for-ensuring-liquid-biopsies-are-ready-for-prime-time/
The Need For Standardizing Pre-Analytical Sample Handling And Integrating Analytical Workflows For Ensuring Liquid Biopsies Are Ready For Prime-Time. [online]. Available at: <https://gradesfixer.com/free-essay-examples/the-need-for-standardizing-pre-analytical-sample-handling-and-integrating-analytical-workflows-for-ensuring-liquid-biopsies-are-ready-for-prime-time/> [Accessed 21 Jan. 2021].
The Need For Standardizing Pre-Analytical Sample Handling And Integrating Analytical Workflows For Ensuring Liquid Biopsies Are Ready For Prime-Time [Internet]. GradesFixer. 2020 Apr 12 [cited 2021 Jan 21]. Available from: https://gradesfixer.com/free-essay-examples/the-need-for-standardizing-pre-analytical-sample-handling-and-integrating-analytical-workflows-for-ensuring-liquid-biopsies-are-ready-for-prime-time/
copy to clipboard
close

Sorry, copying is not allowed on our website. If you’d like this or any other sample, we’ll happily email it to you.

    By clicking “Send”, you agree to our Terms of service and Privacy statement. We will occasionally send you account related emails.

    close

    Attention! this essay is not unique. You can get 100% plagiarism FREE essay in 30sec

    Recieve 100% plagiarism-Free paper just for 4.99$ on email
    get unique paper
    *Public papers are open and may contain not unique content
    download public sample
    close

    Sorry, we cannot unicalize this essay. You can order Unique paper and our professionals Rewrite it for you

    close

    Thanks!

    Your essay sample has been sent.

    Want us to write one just for you? We can custom edit this essay into an original, 100% plagiarism free essay.

    thanks-icon Order now
    boy

    Hi there!

    Are you interested in getting a customized paper?

    Check it out!
    Having trouble finding the perfect essay? We’ve got you covered. Hire a writer

    GradesFixer.com uses cookies. By continuing we’ll assume you board with our cookie policy.